COVID-19 Policies
Issuance Date Title
Draft: Administrative Order June 30, 2021 Draft AO: Guidelines on the Sponsorship of DOH Clinical Trials for COIVD-19 Investigational Products
Department Memorandum 2021-0287 June 18, 2021 Guidelines for the Management and administration of COVID-19 mRNA Vaccine (Nucleoside Modified) Moderna COVID-19 Vaccine
Joint Memorandum Circular 2021-0001 June 03, 2021 Procedures on the Procurement and Distribution of COVID-19 Vaccines for Private Entities
Department Memorandum 2021-0259 May 31, 2021 Implementing Guidelines for Priority Groups A4, A5 and Further Clarification of the National Deployment and Vaccination Plan for COVID-19 Vaccines
Department Memorandum 2021-0223 May 06, 2021 Updated Suggested Retail Price (SRPs) for Emergency Essential Medicines and Medical Devices due to the Coronavirus Disease 2019 (COVID-19) Health Event
Department Memorandum 2021-0197 April 19, 2021 Updated Suggested Retail Price (SRPs) for Emergency Essential Medicines and Medical Devices due to the Coronavirus Disease 2019 (COVID-19) Health Event
Department Memorandum 2021-0175 April 08, 2021 Further Clarification on the National Deployment and Vaccination Plan for COVID-19 Vaccines and Additional Guidelines for Sinovac Implementation
Department Circular 2021-0122 April 05, 2021 Reiteration of Prevention, Detection, Isolation, Treatment, and Reintegration (PDITR) Strategies for COVID-19 in Light of the Implementation of Enhance Community Quarantine in NCR Plus Bubble
Department Memorandum 2021-0161 March 31, 2021 Interim Guidelines for the Conduct of Saliva-Based RT-PCR Testing for the Detection of SARS Cov-2
Department Circular 2021-0118 March 31, 2021 Continuity of Operations of Private COVID-19 Testing Laboratories during the Observance of the Holy Week
Department Memorandum 2021-0157 March 30, 2021 Implementing Guidelines for Priority Group A3 and Further Clarification of the National Deployment and Vaccination Plan for COVID-19 Vaccines
Department Memorandum 2021-0169 March 29, 2021 Interim Guidelines on Rapid Antigen Test Reporting for the NCR Plus Bubble

Pages